Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate ...

How concerned should we be about PFAS in our drinking water? Professor Rainer Lohmann answers this question and more.

Researchers have identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in ...

Women diagnosed with premenstrual symptoms have a slightly increased risk of developing cardiovascular disease later in life.

Scientists have discovered novel drug candidates that could ultimately lead to new effective treatments for conditions caused ...

A University of Colorado study has revealed that dopamine communicates with precise, targeted signals rather than flooding ...

A Weizmann Institute study has identified hundreds of B2-SINE RNA molecules that drive nerve regeneration in mice. These ...

The FDA has released 200+ complete response letters in a bid to offer new insights into drug approval rejections and ...

Adults who stay consistently active throughout their lives can lower their risk of early death by up to 40 percent, a global ...

Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87 ...

In a world-first pilot study, researchers from the University of South Australia have used video footage of insects to ...